RENAISSANCE VENTURE CAPITAL
The Renaissance Venture Capital Fund was formed with the philosophy that venture capital is important for economic growth.
RENAISSANCE VENTURE CAPITAL
Founded:
2008-12-01
Status:
Active
Contact:
(734) 997-8661
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Wordpress Plugins
Similar Organizations
Angel Ventures
Angel Ventures is an early-stage venture capital investment firm.
Maven 11 Capital
Venture Capital Fund in Blockchain & Distributed Ledger Technology (DLT)
Zeev Ventures
Zeev Ventures is an early-stage venture fund that invests in technology, financial, e-commerce, and consumer service sectors.
Current Employees Featured
Chris Rizik
Chris Rizik Founder, Chief Executive Officer & Managing Partner @ Renaissance Venture Capital Founder, Chief Executive Officer & Managing Partner 2008-12-01
Jeffrey Rinvelt
Jeffrey Rinvelt Principal @ Renaissance Venture Capital Principal 2008-12-02
Founder
Chris Rizik
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-07-28 | Strata Oncology | Renaissance Venture Capital investment in Series C - Strata Oncology | 90 M USD |
2021-03-11 | Autobooks | Renaissance Venture Capital investment in Series B - Autobooks | 25 M USD |
2018-05-23 | Strata Oncology | Renaissance Venture Capital investment in Series B - Strata Oncology | 26 M USD |
2017-04-26 | Next Coast Ventures | Renaissance Venture Capital investment in Venture Round - Next Coast Ventures | N/A |
2017-04-11 | Cirius Therapeutics | Renaissance Venture Capital investment in Series A - Cirius Therapeutics | 40 M USD |
2016-01-05 | Millendo Therapeutics | Renaissance Venture Capital investment in Series B - Millendo Therapeutics | 62 M USD |
2015-09-14 | Atlas Venture | Renaissance Venture Capital investment in Venture Round - Atlas Venture | N/A |
2014-02-10 | ArborMetrix | Renaissance Venture Capital investment in Series B - ArborMetrix | 1.3 M USD |
2013-10-17 | Swift Biosciences | Renaissance Venture Capital investment in Series B - Swift Biosciences | 7 M USD |
2013-05-20 | Fidelis SeniorCare | Renaissance Venture Capital investment in Series A - Fidelis SeniorCare | 20.5 M USD |